Dyne Medical Group Successfully Demonstrates ‘URUS’ Single-use Ureteroscope at Major Hospitals on U.S. East and West Coasts
6 o’clock working channel design earns high praise from clinicians—signals Dyne Medical’s official entry into the North American market
바로가기 복사하기 본문 글씨 줄이기 본문 글씨
SNS 기사보내기
페이스북(으)로 기사보내기 트위터(으)로 기사보내기 카카오스토리(으)로 기사보내기 URL복사(으)로 기사보내기 이메일(으)로 기사보내기 다른 공유 찾기 기사스크랩하기 Dyne Medical Group (CEO Sunghoon Lee), a company specializing in medical devices, announced on the 25th that its URUS single-use ureteroscope has been used for the first time at leading hospitals on both the East and West Coasts of the United States—marking a significant milestone toward entering the North American market.
From left: Jason Ott, co-CEO of the local distributor; Professor Fernando J Kim; Chulseok Kim, Vice President of Dyne Medical Group
On the East Coast, Professor Fernando J Kim—an esteemed urologist with extensive clinical experience—successfully performed the first kidney stone removal surgery in the U.S. using URUS at AdventHealth Riverview in Florida.
On the West Coast, Professor Seth Bechis at UC San Diego Health's Hillcrest Medical Center performed the first procedure in the region using the device.
UC San Diego Health is a leading academic medical center, consistently ranked among the best hospitals in the U.S. by U.S. News & World Report, and is renowned for its commitment to innovative medical technologies and research-based care.
Meanwhile, AdventHealth, which hosted the East Coast demonstration, operates over 50 hospitals across nine U.S. states and is known for its patient-centered services and high clinical standards.
These successful demonstrations at highly respected institutions in the U.S. not only validate the clinical efficacy and practicality of URUS but also signify promising opportunities for Dyne Medical Group's expansion into the American market.
Both surgeons involved in the procedures gave positive feedback on the device’s unique design. URUS is the only single-use ureteroscope currently on the market with a 6 o’clock-positioned working channel. This provides "Balanced Visualization," avoiding lateral visual bias during procedures and easing wrist strain through ergonomic design and enhanced usability.
Professor Kim noted, “The 6 o’clock working channel allowed for a more balanced field of view and stable access even in anatomically complex cases. Compared to conventional scopes, the reduced wrist strain made the procedure more comfortable and faster.”
Professor Seth Bechis (left) successfully performed surgery on a kidney stone patient using URUS at UC San Diego Health.
Professor Bechis added, “URUS required less excessive wrist movement, reducing fatigue significantly during the procedure. Its handling was intuitive, and despite being a disposable device, its performance and durability were highly satisfactory.”
Chulseok Kim, Vice President overseeing Dyne Medical Group's U.S. market strategy, stated, “It’s highly meaningful that leading American institutions have chosen to adopt our technology.”
He continued, “With this first adoption on both coasts, we aim to promote the clinical value of URUS to more hospitals and healthcare professionals, and to strengthen our position in the U.S. medical device market.”
Moving forward, Dyne Medical Group plans to continue leading innovation in the clinical field through ongoing R&D and global collaborations with medical professionals, offering patient-centered, cutting-edge medical solutions.
Dyne Medical Group Successfully Demonstrates ‘URUS’ Single-use Ureteroscope at Major Hospitals on U.S. East and West Coasts
6 o’clock working channel design earns high praise from clinicians—signals Dyne Medical’s official entry into the North American market
SNS 기사보내기
페이스북(으)로 기사보내기 트위터(으)로 기사보내기 카카오스토리(으)로 기사보내기 URL복사(으)로 기사보내기 이메일(으)로 기사보내기 다른 공유 찾기 기사스크랩하기Dyne Medical Group (CEO Sunghoon Lee), a company specializing in medical devices, announced on the 25th that its URUS single-use ureteroscope has been used for the first time at leading hospitals on both the East and West Coasts of the United States—marking a significant milestone toward entering the North American market.
From left: Jason Ott, co-CEO of the local distributor; Professor Fernando J Kim; Chulseok Kim, Vice President of Dyne Medical Group
On the East Coast, Professor Fernando J Kim—an esteemed urologist with extensive clinical experience—successfully performed the first kidney stone removal surgery in the U.S. using URUS at AdventHealth Riverview in Florida.
On the West Coast, Professor Seth Bechis at UC San Diego Health's Hillcrest Medical Center performed the first procedure in the region using the device.
UC San Diego Health is a leading academic medical center, consistently ranked among the best hospitals in the U.S. by U.S. News & World Report, and is renowned for its commitment to innovative medical technologies and research-based care.
Meanwhile, AdventHealth, which hosted the East Coast demonstration, operates over 50 hospitals across nine U.S. states and is known for its patient-centered services and high clinical standards.
These successful demonstrations at highly respected institutions in the U.S. not only validate the clinical efficacy and practicality of URUS but also signify promising opportunities for Dyne Medical Group's expansion into the American market.
Both surgeons involved in the procedures gave positive feedback on the device’s unique design. URUS is the only single-use ureteroscope currently on the market with a 6 o’clock-positioned working channel. This provides "Balanced Visualization," avoiding lateral visual bias during procedures and easing wrist strain through ergonomic design and enhanced usability.
Professor Kim noted, “The 6 o’clock working channel allowed for a more balanced field of view and stable access even in anatomically complex cases. Compared to conventional scopes, the reduced wrist strain made the procedure more comfortable and faster.”
Professor Seth Bechis (left) successfully performed surgery on a kidney stone patient using URUS at UC San Diego Health.
Professor Bechis added, “URUS required less excessive wrist movement, reducing fatigue significantly during the procedure. Its handling was intuitive, and despite being a disposable device, its performance and durability were highly satisfactory.”
Chulseok Kim, Vice President overseeing Dyne Medical Group's U.S. market strategy, stated, “It’s highly meaningful that leading American institutions have chosen to adopt our technology.”
He continued, “With this first adoption on both coasts, we aim to promote the clinical value of URUS to more hospitals and healthcare professionals, and to strengthen our position in the U.S. medical device market.”
Moving forward, Dyne Medical Group plans to continue leading innovation in the clinical field through ongoing R&D and global collaborations with medical professionals, offering patient-centered, cutting-edge medical solutions.